Triolab. The partnership will see
Triolab take point as the sole provider of
PixCell s AI diagnostic solution in Sweden, with potential to expand into the rest of Scandinavia and the Baltics.
Pixcell Medical has developed a fast-working blood diagnostic device that can be used by physicians at point-of-care. Requiring no maintenance or qualified personnel, the HemoScreen diagnostic device delivers complete-blood-counts (CBC) within six minutes at the point-of-care. With lab-like diagnostic results, combining standard testing with AI technologies has led the company to secure both CE and FDA clearance.
“
PixCell’s HemoScreen brings lab-quality hematology results closer to the patient, making it possible to analyze Complete Blood Count (CBC) with the five-part differential at a patient’s bedside, without the skills of a biomedical scientist, which is a prerequisite for traditional hematology,” said Johan Snis, Sales Manager of
With CE approval in the bag, IMedis targets FDA OK
The Israeli MedTech startup looks to empower radiology workflow with an AI-powered diagnostic platform. Dor Schwartz /
Israeli MedTech startup
IMedis, which develops an AI-powered radiology diagnostics assistant, announced that it has received the CE approval and can now market and sell its solution across the EU and UK.
A second pair of eyes
IMedis CEO Aviel Blumenfeld commented on the company’s recent milestone, saying that “obtaining CE approval is an essential milestone for
IMedis, an idea that was born as a result of understanding the need to harness technology in order to assist in reducing diagnostic errors.
Philips & InSightec join forces to usher in the future of patient care
Insightec builds on 2020 momentum collaborating with one of the world s largest diagnostic imaging conglomerates. Dor Schwartz /
Israeli MedTech veteran
InSightec, innovator of MR-guided Focused Ultrasound solution, and
Royal Philips (NYSE: PHG), a multinational leader in health technology announced a collaboration to expand access to MR-guided Focused Ultrasound.
InSightec’s Exablate Neuro uses focused acoustic energy to precisely target and treat deep in the brain without incisions or implants. MR imaging provides high-resolution imaging and acts as a thermometer for real-time temperature monitoring. The incisionless treatment option is often performed in an outpatient setting. When used to treat Essential Tremor or Tremor-dominant Parkinson’s Disease, many patients demonstrated immediate tremor relief with minimal complications.
Results for
Zebra Medical Vision secures 7th FDA clearance for pre-opt AI bone sizing
The Israeli startup sets up camp at the FDA. This time providing an alternative imaging solution powered by AI for those without access to CT or MRI. Dor Schwartz / 10 Dec 2020 • 2 min read
Israeli MedTech companies have experienced quite the acceleration process following the COVID-19 outbreak, with digital health companies garnering the bulk of the focus. The AI medical train has left the station with companies like
Ibex Medical, Aidoc, Scopio, and more all scoring funding and coveted FDA approvals this year. However, in the land of medical-AI FDA clearances, one horse stands alone, or should I say Zebra.